Article metrics

Download PDFPDF

Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to April 2021

AbstractFullPdf
Dec 2019221
Jan 202013133
Feb 2020434311
Mar 2020515117
Apr 202044447
May 2020606011
Jun 202035357
Jul 2020232317
Aug 2020343426
Sep 2020919137
Oct 2020898735
Nov 2020767535
Dec 2020555527
Jan 2021606030
Feb 202110310341
Mar 2021777758
Apr 2021757537
Total931928400